ARRIVENT BIOPHARMA INC (AVBP) Institutional Shareholders

ARRIVENT BIOPHARMA INC (AVBP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $1.60B in AVBP holdings during the latest filing period.

Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of AVBP tracked by InsiderSet, reporting ownership valued at approximately $156.87M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $131.00M, representing an estimated loss of -16.49% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 63% of the total disclosed AVBP value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Infinitum Asset Management, Llc, Hhlr Advisors, Ltd., and several other long-term asset managers with concentrated positions in ARRIVENT BIOPHARMA INC (AVBP).

This page ranks the largest institutional AVBP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

158

Total Reported Value

$1.60B

Largest Holder

Suvretta Capital Management, Llc

Largest Position

$156.87M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

115

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Suvretta Capital Management, Llc3.30%4,515,531$156,869,547$130,995,554-$25,873,993-16.49%
Infinitum Asset Management, Llc15.68%4,438,384$154,189,460$128,757,520-$25,431,940-16.49%
Hhlr Advisors, Ltd.16.40%3,929,117$136,497,525$113,983,684-$22,513,841-16.49%
Blackrock, Inc.0.00%3,250,396$112,918,757$94,293,988-$18,624,769-16.49%
Orbimed Advisors Llc1.99%3,027,328$105,169,375$87,822,785-$17,346,590-16.49%
Fmr Llc0.00%2,778,959$96,541,033$80,617,601-$15,923,432-16.49%
Octagon Capital Advisors Lp6.28%1,971,054$68,474,416$57,180,277-$11,294,139-16.49%
Vanguard Capital Management Llc0.00%1,774,873$61,659,088$51,489,066-$10,170,022-16.49%
Sofinnova Investments, Inc.3.15%1,696,752$58,945,164$49,222,776-$9,722,388-16.49%
State Street Corp0.00%1,692,986$58,814,334$49,113,524-$9,700,810-16.49%
Vivo Capital, Llc5.34%1,682,097$58,436,050$48,797,634-$9,638,416-16.49%
Novo Holdings A/S3.03%1,500,000$52,110,000$43,515,000-$8,595,000-16.49%
General Catalyst Group Management, Llc27.55%1,494,786$51,928,866$43,363,742-$8,565,124-16.49%
Logos Global Management Lp1.50%1,000,000$34,740,000$29,010,000-$5,730,000-16.49%
Geode Capital Management, Llc0.00%972,626$33,795,640$28,215,880-$5,579,760-16.51%
D. E. Shaw & Co., Inc.0.02%872,011$30,293,662$25,297,039-$4,996,623-16.49%
Goldman Sachs Group Inc0.00%853,723$29,658,337$24,766,504-$4,891,833-16.49%
Hsg Holding Ltd1.92%663,308$23,043,320$19,242,565-$3,800,755-16.49%
Point72 Asset Management, L.P.0.03%566,796$19,690,493$16,442,752-$3,247,741-16.49%
Millennium Management Llc0.01%438,664$15,239,187$12,725,643-$2,513,544-16.49%
Ubs Group Ag0.00%438,594$15,236,756$12,723,612-$2,513,144-16.49%
Balyasny Asset Management L.P.0.03%395,447$13,737,829$11,471,917-$2,265,912-16.49%
Ameriprise Financial Inc0.00%381,589$13,256,401$11,069,897-$2,186,504-16.49%
Vanguard Portfolio Management Llc0.00%335,320$11,649,017$9,727,633-$1,921,384-16.49%
Northern Trust Corp0.00%332,753$11,559,840$9,653,165-$1,906,675-16.49%
Foresite Capital Management Vi Llc1.63%301,341$10,468,586$8,741,902-$1,726,684-16.49%
Charles Schwab Investment Management Inc0.00%294,224$10,221,342$8,535,438-$1,685,904-16.49%
Sixth Street Partners Management Company, L.P.0.00%294,224$10,221,342$8,535,438-$1,685,904-16.49%
Vanguard Fiduciary Trust Co0.00%259,290$9,007,735$7,522,003-$1,485,732-16.49%
Seven Fleet Capital Management Lp1.41%246,606$8,567,092$7,154,040-$1,413,052-16.49%
Acuta Capital Partners, Llc5.29%218,694$7,597,430$6,344,313-$1,253,117-16.49%
Dimensional Fund Advisors Lp0.00%211,509$7,347,651$6,135,876-$1,211,775-16.49%
Morgan Stanley0.00%189,910$6,597,474$5,509,289-$1,088,185-16.49%
Bank Of America Corp0.00%174,866$6,074,845$5,072,863-$1,001,982-16.49%
Citadel Advisors Llc0.00%156,742$5,445,217$4,547,085-$898,132-16.49%
Nomura Holdings Inc0.02%154,617$5,371,395$4,485,439-$885,956-16.49%
Woodline Partners Lp0.02%147,639$5,128,979$4,283,007-$845,972-16.49%
Affinity Asset Advisors, Llc0.21%125,000$4,342,500$3,626,250-$716,250-16.49%
E Fund Management Co., Ltd.0.09%109,328$3,798,055$3,171,605-$626,450-16.49%
Nuveen, Llc0.00%107,851$3,746,745$3,128,758-$617,987-16.49%
Bank Of New York Mellon Corp0.00%103,931$3,610,563$3,015,038-$595,525-16.49%
Kvp Capital Advisors, Lp2.60%102,000$3,543,480$2,959,020-$584,460-16.49%
Wellington Management Group Llp0.00%100,855$3,503,702$2,925,804-$577,898-16.49%
Burkehill Global Management, Lp0.13%100,000$3,474,000$2,901,000-$573,000-16.49%
Sectoral Asset Management Inc1.92%79,043$2,745,954$2,293,037-$452,917-16.49%
Trexquant Investment Lp0.02%71,860$2,496,416$2,084,659-$411,757-16.49%
Barclays Plc0.00%70,970$2,465,497$2,058,840-$406,657-16.49%
Jpmorgan Chase & Co0.00%65,692$2,257,834$1,905,725-$352,109-15.59%
Xtx Topco Ltd0.03%62,332$2,165,414$1,808,251-$357,163-16.49%
Two Sigma Investments, Lp0.00%57,804$2,008,111$1,676,894-$331,217-16.49%

Frequently asked questions about AVBP

  • Who owns the most AVBP stock?

    The largest holders of AVBP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ARRIVENT BIOPHARMA INC (AVBP).

  • Is AVBP widely held by superinvestors?

    Many widely followed stocks like AVBP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AVBP is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.